Warning letterFDA · Nov 14, 2022
Essential Elements MARCS-CMS 636305, November 14, 2022
Named company: Essential Elements
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, CholestAid fails to bear adequate directions…
